Biotech Law Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Biotech Law Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Astellas Pharma, Inc.
Astellas and MerLion Pharmaceuticals announce new drug discovery agreement
November 4th, 2005
Astellas Pharma, Inc., of Tokyo, Japan, and MerLion Pharmaceuticals Pte, Ltd., of Singapore, signed a collaborative agreement to discover and develop new drug candidates derived from natural products chemistry. Under the collaboration agreement, MerLion will receive a pipeline of validated drug targets from the Astellas portfolio and will utilize its extensive natural sample collection, its modern high throughput screening facilities and experienced natural products chemistry skills for the identification of new chemical seeds. Astellas will conduct the optimization of such novel compounds and generate drug candidates for future development. ...
Source: Biotech Law Weekly (2005-11-04)
|
